Marijuana 1-to-3 Act of 2023
Introduced in House (01/27/2023)
This bill moves marijuana to a lower schedule of the Controlled Substances Act.
Specifically, it directs the Drug Enforcement Administration to transfer marijuana from schedule I to schedule III. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; that has no currently accepted medical use; and that is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. A schedule III controlled substance is a drug, substance, or chemical that has less potential for abuse than a schedule I or II substance; that has a currently accepted medical use; and that has low or moderate risk of dependence if abused.
February 10, 2023, Rep. Greg Steube (R-FL) re-introduced legislation titled the “Marijuana 1-to-3 Act.” As stated, the bill would require the attorney general to move cannabis from Schedule I to Schedule III under the Controlled Substances Act, with the goal of expanding research on the drug’s effects.
“As marijuana is legalized for medical and recreational use across the United States, it is important that we study the effects of the substance and the potential impacts it can have on various populations,” Steube said in a press release. “By rescheduling marijuana from a schedule I controlled substance to a schedule III controlled substance, the opportunities for research and study are drastically expanded.”
